Human Sporadic Prion Diseases

作者: Pierluigi Gambetti , Silvio Notari

DOI: 10.1007/978-1-4614-5338-3_4

关键词:

摘要: Sporadic prion diseases account for approximately 85% of all human diseases. They include sporadic Creutzfeldt–Jakob disease (sCJD), which affect over 90% the cases, as well fatal insomnia (sFI) and variably protease-sensitive prionopathy (VPSPr), 1–2% 3–4% respectively. CJD comprises five phenotypically distinct subtypes most are associated with molecular features. The signature each subtype is determined by pairing genotype at methionine/valine polymorphic codon 129 protein (PrP) gene either one two disease-associated PrP (PrPDis) types characterized physico-chemical characteristics. VPSPr may three similarly whereas no known in sFI. Currently, likely etiological-pathogenetic mechanism failure quality control complex permitting presence conformationally abnormal pathogenic variants capable converting normal into conformers. These conformers then propagate damage vulnerable tissues they populate. Essentially same sequence basic events play out other forming amyloids such Alzheimer’s major neurodegenerative type 2 diabetes amyloid A (AA).

参考文章(67)
N K Gonatas, J L Cornog, J R Feierman, Effects of intracerebral injection of ouabain on the fine structure of rat cerebral cortex. American Journal of Pathology. ,vol. 51, pp. 573- 590 ,(1967)
Y. S. Eisele, U. Obermuller, G. Heilbronner, F. Baumann, S. A. Kaeser, H. Wolburg, L. C. Walker, M. Staufenbiel, M. Heikenwalder, M. Jucker, Peripherally Applied Aβ-Containing Inoculates Induce Cerebral β-Amyloidosis Science. ,vol. 330, pp. 980- 982 ,(2010) , 10.1126/SCIENCE.1194516
Fabio Moda, Silvia Suardi, Giuseppe Di Fede, Antonio Indaco, Lucia Limido, Chiara Vimercati, Margherita Ruggerone, Ilaria Campagnani, Jan Langeveld, Alessandro Terruzzi, Antonio Brambilla, Pietro Zerbi, Paolo Fociani, Matthew T. Bishop, Robert G. Will, Jean C. Manson, Giorgio Giaccone, Fabrizio Tagliavini, MM2-thalamic Creutzfeldt-Jakob disease: neuropathological, biochemical and transmission studies identify a distinctive prion strain Brain Pathology. ,vol. 22, pp. 662- 669 ,(2012) , 10.1111/J.1750-3639.2012.00572.X
Alfredo Ulloa-Aguirre, Jo Ann Janovick, Shaun P. Brothers, P. Michael Conn, Pharmacologic rescue of conformationally-defective proteins: implications for the treatment of human disease. Traffic. ,vol. 5, pp. 821- 837 ,(2004) , 10.1111/J.1600-0854.2004.00232.X
Davis M. Seelig, Gary L. Mason, Glenn C. Telling, Edward A. Hoover, Chronic Wasting Disease Prion Trafficking via the Autonomic Nervous System The American Journal of Pathology. ,vol. 179, pp. 1319- 1328 ,(2011) , 10.1016/J.AJPATH.2011.05.057
Pei-Hsien Ren, Jane E. Lauckner, Ioulia Kachirskaia, John E. Heuser, Ronald Melki, Ron R. Kopito, Cytoplasmic Penetration and Persistent Infection of Mammalian Cells by Polyglutamine Aggregates Nature Cell Biology. ,vol. 11, pp. 219- 225 ,(2009) , 10.1038/NCB1830
Charles Weissmann, Jiali Li, Sukhvir P. Mahal, Shawn Browning, Prions on the move EMBO Reports. ,vol. 12, pp. 1109- 1117 ,(2011) , 10.1038/EMBOR.2011.192
J. Collinge, A. R. Clarke, A General Model of Prion Strains and Their Pathogenicity Science. ,vol. 318, pp. 930- 936 ,(2007) , 10.1126/SCIENCE.1138718
Malin K. Sandberg, Huda Al-Doujaily, Bernadette Sharps, Anthony R. Clarke, John Collinge, Prion propagation and toxicity in vivo occur in two distinct mechanistic phases Nature. ,vol. 470, pp. 540- 542 ,(2011) , 10.1038/NATURE09768